- Conditions: Cardiopulmonary Bypass; Altered Heparin Response
Interventions: Drug: Heparin; Drug: ATryn
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; GTC Biotherapeutics
Not yet recruiting - verified May 2012 - Condition: Ischemic Stroke
Interventions: Drug: Argatroban; Drug: Argatroban
Sponsors: The University of Texas Health Science Center, Houston; Andrew Barreto
Recruiting - verified November 2011 - Condition: Coronary Artery Disease
Interventions: Drug: Bivalirudin; Drug: Heparin
Sponsors: Stony Brook University; Stony Brook University
Recruiting - verified October 2011 - Condition: Postoperative Hemorrhage
Interventions: Drug: Antithrombin (Recombinant); Other: Placebo
Sponsors: Medical College of Wisconsin; Medical College of Wisconsin; Children's Research Institute; GTC Biotherapeutics
Recruiting - verified November 2011 - Conditions: Sickle Cell Disease; Hemolytic Anemia
Interventions: Procedure: Clinical Evaluations; Other: Laboratory Studies
Sponsors: St. Jude Children's Research Hospital; St. Jude Children's Research Hospital
Recruiting - verified February 2012 - Condition: Deep Venous Thrombosis
Intervention: Drug: Bivalirudin
Sponsors: Children's Hospital Los Angeles; Children's Hospital Los Angeles; Texas Children's Hospital; Children's Hospital Colorad; Children's Hospital of Philadelphia; Nationwide Children's Hospital; University of Texas Southwestern Medical Center
Recruiting - verified May 2011 - Condition: Carotid Artery Disease
Intervention: Device: RX ACCULINK™ Carotid Stent System; RX ACCUNET™ Embolic Protection System; PercuSurge GuardWire® 3-6 Temporary Occlusion and Aspiration System
Sponsors: Medstar Research Institute; Medstar Research Institute
Recruiting - verified April 2012 - Condition: Antithrombin III Deficiency
Intervention: Drug: Plasma-derived AT-III concentrate
Sponsors: Grifols Biologicals Inc.; Grifols Biologicals Inc.
Recruiting - verified March 2012
 |
Antithrombin III Clinical Trials |
